Flavie Arbion

1.6k total citations
68 papers, 838 citations indexed

About

Flavie Arbion is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Flavie Arbion has authored 68 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cancer Research, 25 papers in Oncology and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Flavie Arbion's work include Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (14 papers) and Cancer and Skin Lesions (8 papers). Flavie Arbion is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Breast Lesions and Carcinomas (14 papers) and Cancer and Skin Lesions (8 papers). Flavie Arbion collaborates with scholars based in France, Germany and United States. Flavie Arbion's co-authors include G. Body, Lobna Ouldamer, Philippe Bougnoux, L. Brunereau, Fabrice Denis, Gaëlle Fromont, Michelle Pinault, Patrick Michenet, Caroline Goupille and Pierre Besson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Flavie Arbion

63 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flavie Arbion France 15 252 242 188 158 125 68 838
Hong Lu China 18 204 0.8× 263 1.1× 127 0.7× 257 1.6× 286 2.3× 63 910
Piotr Donizy Poland 18 460 1.8× 157 0.6× 57 0.3× 427 2.7× 57 0.5× 90 1.0k
A. Nagano United Kingdom 13 243 1.0× 149 0.6× 36 0.2× 254 1.6× 47 0.4× 22 778
Virinder Kaur Sarhadi Finland 21 384 1.5× 510 2.1× 121 0.6× 737 4.7× 38 0.3× 45 1.4k
Elisabeth Heere‐Ress Austria 16 402 1.6× 80 0.3× 50 0.3× 732 4.6× 57 0.5× 21 1.1k
Marion Wobser Germany 20 446 1.8× 57 0.2× 290 1.5× 323 2.0× 20 0.2× 78 1.1k
Sunandana Chandra United States 16 817 3.2× 122 0.5× 66 0.4× 424 2.7× 41 0.3× 49 1.2k
Amanda Charlton Australia 16 217 0.9× 54 0.2× 293 1.6× 441 2.8× 19 0.2× 46 1.1k
Chaoran Yu China 19 279 1.1× 147 0.6× 81 0.4× 281 1.8× 59 0.5× 47 862
Michelle Goh Australia 16 152 0.6× 147 0.6× 114 0.6× 569 3.6× 8 0.1× 43 1.1k

Countries citing papers authored by Flavie Arbion

Since Specialization
Citations

This map shows the geographic impact of Flavie Arbion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavie Arbion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavie Arbion more than expected).

Fields of papers citing papers by Flavie Arbion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavie Arbion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavie Arbion. The network helps show where Flavie Arbion may publish in the future.

Co-authorship network of co-authors of Flavie Arbion

This figure shows the co-authorship network connecting the top 25 collaborators of Flavie Arbion. A scholar is included among the top collaborators of Flavie Arbion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavie Arbion. Flavie Arbion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arbion, Flavie, Cyril Touboul, Yohann Dabi, et al.. (2025). Association between treatment center volume and survival of endometrial cancer patients: A multicenter study: A Francogyn group study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 306. 194–198.
2.
Goupille, Caroline, et al.. (2023). Prognostic value of axillary lymph node metastases in invasive lobular breast carcinoma. Journal of Gynecology Obstetrics and Human Reproduction. 52(10). 102665–102665. 2 indexed citations
3.
Arbion, Flavie, et al.. (2020). Negative estrogen receptors and positive progesterone receptors breast cancers. Journal of Gynecology Obstetrics and Human Reproduction. 50(2). 101928–101928. 3 indexed citations
4.
Goupille, Caroline, Lobna Ouldamer, Michelle Pinault, et al.. (2020). Identification of a Positive Association between Mammary Adipose Cholesterol Content and Indicators of Breast Cancer Aggressiveness in a French Population. Journal of Nutrition. 151(5). 1119–1127. 5 indexed citations
5.
Arbion, Flavie, et al.. (2020). Predictive factors of major deviation (>20 mm) between lesion sizes measured by magnetic resonance imaging and histology for invasive lobular breast cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 251. 14–19. 1 indexed citations
6.
Arbion, Flavie, et al.. (2019). Evolution of characteristics of women with endometrial cancer during a 40 years study period. Journal of Gynecology Obstetrics and Human Reproduction. 48(7). 489–494. 1 indexed citations
7.
Jourdan, M, et al.. (2018). Cancer du sein chez les patientes de moins de 40 ans : présentation et caractéristiques évolutives. Gynécologie Obstétrique Fertilité & Sénologie . 46(2). 105–111.
8.
Ouldamer, Lobna, et al.. (2018). Axillary lymph node metastases from unknown primary: A French multicentre study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 223. 103–107. 5 indexed citations
9.
Jourdan, M, et al.. (2017). Facteurs prédictifs de traitement conservateur après chimiothérapie néo-adjuvante dans le cancer du sein. Gynécologie Obstétrique Fertilité & Sénologie . 45(9). 466–471.
10.
Chalopin, Thomas, I. Barillot, Flavie Arbion, et al.. (2017). Primary solitary plasmacytoma of the liver – successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case report. Journal of Medical Case Reports. 11(1). 193–193. 5 indexed citations
11.
Régina, Sandra, et al.. (2016). A CASE OF CHORIORETINOPATHY AS FIRST MANIFESTATION OF HODGKIN'S LYMPHOMA. Retinal Cases & Brief Reports. 10(3). 239–243. 1 indexed citations
12.
Ouldamer, Lobna, Caroline Goupille, Flavie Arbion, et al.. (2016). N-3 Polyunsaturated Fatty Acids of Marine Origin and Multifocality in Human Breast Cancer. PLoS ONE. 11(1). e0147148–e0147148. 17 indexed citations
13.
Ouldamer, Lobna, Caroline Lacoste, Flavie Arbion, et al.. (2015). Is there a justification for hysterectomy in patients with borderline ovarian tumors?. Surgical Oncology. 25(1). 1–5. 9 indexed citations
14.
15.
Chantôme, Aurélie, Marie Potier‐Cartereau, Lucie Clarysse, et al.. (2013). Pivotal Role of the Lipid Raft SK3–Orai1 Complex in Human Cancer Cell Migration and Bone Metastases. Cancer Research. 73(15). 4852–4861. 151 indexed citations
16.
17.
Ouldamer, Lobna, et al.. (2013). Risk of Incidental Finding of Endometrial Cancer at the Time of Hysterectomy for Benign Condition. Journal of Minimally Invasive Gynecology. 21(1). 131–135. 19 indexed citations
18.
Ouldamer, Lobna, et al.. (2010). Mucocèles du sein : conduite à tenir après diagnostic sur micro- ou macrobiopsie. Gynécologie Obstétrique & Fertilité. 38(7-8). 455–459. 4 indexed citations
19.
Blouin, Pascale, Flavie Arbion, Anne Pagnier, et al.. (2010). Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA‐AraC. Pediatric Blood & Cancer. 55(4). 757–760. 8 indexed citations
20.
Denis, Fabrice, et al.. (2004). Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. European Journal of Surgical Oncology. 30(10). 1069–1076. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Lu Breakdown of academic impact, for papers by Piotr Donizy Breakdown of academic impact, for papers by A. Nagano Breakdown of academic impact, for papers by Virinder Kaur Sarhadi Breakdown of academic impact, for papers by Elisabeth Heere‐Ress Breakdown of academic impact, for papers by Marion Wobser Breakdown of academic impact, for papers by Sunandana Chandra Breakdown of academic impact, for papers by Amanda Charlton Breakdown of academic impact, for papers by Chaoran Yu Breakdown of academic impact, for papers by Michelle Goh
Rankless by CCL
2026